Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02007512
Title Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications

breast cancer

Therapies

Enzalutamide + Exemestane

Exemestane

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN | BEL


No variant requirements are available.